These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 80674)

  • 1. Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.
    Menon C; Berry EW; Ockelford P
    Lancet; 1978 Sep; 2(8092 Pt 1):743-4. PubMed ID: 80674
    [No Abstract]   [Full Text] [Related]  

  • 2. Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.
    Isola L; Forster A; Aledort LM
    Ann Intern Med; 1984 Nov; 101(5):719-20. PubMed ID: 6435493
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of deamino-8-D arginine vasopressin in a patient with moderate von Willebrand's disease.
    Abubaker AO; Bontempo FA; Braun TW
    J Oral Maxillofac Surg; 1987 Aug; 45(8):728-30. PubMed ID: 3497245
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
    Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
    Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
    Takahashi H
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
    Shiraishi K; Ebata H; Sato K; Tanaka M; Nouno R; Mashiko N; Yamaguchi G; Kubo Y; Tanikawa K; Ide K
    Rinsho Ketsueki; 1983 Dec; 24(12):1674-9. PubMed ID: 6608600
    [No Abstract]   [Full Text] [Related]  

  • 7. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
    de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
    Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
    Theiss W; Schmidt G
    Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
    [No Abstract]   [Full Text] [Related]  

  • 10. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
    Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
    Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
    Streit A; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1389-91. PubMed ID: 6333722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract]   [Full Text] [Related]  

  • 14. [The advantages and limits of the use of desmopressin (Minirin) in stomatology. Apropos 2 young female patients presenting with von Willebrand's disease].
    Vicens G; Mathiot JL; Mettoudi JD; Maillet S; Ky BK; Ginisty D
    Rev Stomatol Chir Maxillofac; 1992; 93(2):127-9. PubMed ID: 1626188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.
    Mannucci PM; Ruggeri ZM; Pareti FI; Capitanio A
    Lancet; 1977 Apr; 1(8017):869-72. PubMed ID: 67283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
    Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
    Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 18. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
    Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
    Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.